Long-term release of clodronate from biodegradable microspheres

AAPS PharmSciTech

Volumn 2, Issue 3, 2001, Pages

  Perugini, Paola ^a   Genta, Ida ^a   Conti, Bice ^a   Modena, Tiziana ^a   Pavanetto, Franca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Clodronate; Long term release; PLGA microspheres; Solvent evaporation method

Indexed keywords

CARBOXYMETHYLCELLULOSE; CLODRONIC ACID; COPPER SULFATE; DRUG ADDITIVE; MICROSPHERE; NITRIC ACID; OIL; POLYGLACTIN; POLYLACTIC ACID; SOLVENT; SURFACTANT; WATER;

AQUEOUS SOLUTION; ARTICLE; BIODEGRADABILITY; CALIBRATION; CHEMICAL COMPOSITION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; EMULSION; EVAPORATION; IN VITRO STUDY; MICROENCAPSULATION; MOLECULAR WEIGHT; PARTICLE SIZE; SPECTROPHOTOMETRY; TEMPERATURE DEPENDENCE;

EID: 23144436083     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt020310     Document Type: Article

References (16)

1. PD Delmas, PJ Meunier. The management of Paget's disease of bone. New Engl J Med. 1997;336:558-566.
2. JA Kanis. Rationale for the use of bisphosphonates in breast cancer. Acta Oncol. 1996;35(Suppl 5):61-67.
3. H Fleisch. Bisphosphonates: preclinical aspects and use in osteoporosis. Ann Med. 1997;29:55-62.
4. H Shinoda, G Adamek, R Felix, H Fleish, R Schenk. Structure-activity relationship of various bisphosphonates. Calc Tissue Int. 1983;35:87-99.
5. GJ Yakatan, WJ Poynor, RL Talbert, et al. Clodronate kinetics and bioavailability. Clin Pharmacol Ther. 1982;31:402-410.
6. L Lauren, T Osterman, T Karhi. Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats. Pharmacol Toxicol. 1991;69:365-368.
7. M Rossini, D Gatti, D Gerardi, N Zamberlan, V Braga, S Adami. Intramuscular clodronate therapy in postmenopausal osteoporosis. Bone. 1999;24:125-129.
8. A Ezra, G Golomb. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Del Rev. 2000;42:175-195.
9. S Patashnik, L Rabinovich, G Golomb. Preparation and evaluation of chitosan microspheres containing bisphosphonates. J Drug Targ. 1997;4:371-380.
10. H Okada, H Toguchi. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst. 1995;12:1-99.
11. S Gogolewski, P Mainil-Varlet. Effect of thermal treatment on sterility, molecular and mechanical properties of various polylactides. Biomaterials. 1997;18:251-255.
12. S Cohen, T Yoshioka, M Lucarelli, LH Hwang, R Langer. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 1991;8:713-720.
13. D Ostovic, C Stelmach, B Hulshizer. Formation of a chromophoric complex between alendronate and copper (II) ions. Pharm Res. 1993;10:470-472.
14. T Uchida, K Yoshida, S Goto. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. J Microencapsul. 1996;13:219-228.
15. Y Ogawa, M Yamamoto, H Okada, T Yashiki, T Shimamoto. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly (lactic/glycolic) acid. Chem Pharm Bull. 1988;36:1095-1103.
16. RW Baker. Biodegradable systems. In: R Baker, ed. Controlled release of biologically active agents. New York: John Wiley & Sons; 1987:84-131